Karin Haustermans
Papers
2
Total Citations
37
H-Index
2
About
Karin Haustermans is a leading figure in radiation oncology, with a career dedicated to refining the treatment of prostate cancer through precision medicine and evidence-based practice. Her research focuses on integrating advanced imaging, particularly magnetic resonance imaging (MRI), into clinical staging and risk classification. A landmark 2019 study, cited 35 times, demonstrated how MRI significantly improves the accuracy of prostate cancer staging and reclassifies patients according to European Association of Urology risk groups, directly impacting treatment decisions. Haustermans also investigates patterns of care and outcomes in postoperative radiotherapy. Her population-based cohort study on adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy revealed that the availability of a radiation therapy department at the surgical center is a strong, independent predictor of receiving postoperative treatment, highlighting systemic factors that influence clinical practice. This work underscores her commitment to bridging the gap between clinical evidence and real-world application, making her a pivotal voice in optimizing multimodal prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2